Efficacy / Effect
Immunization against infection caused by all known subtypes of Hepatitis B virus
0.5 mL (10 μg HBsAg) is administered to neonates, infants, and children aged up to 15 years and 1.0 mL (20 μg HBsAg) is administered to adults aged from 16 years, by intramuscular injection
* Basic immunization schedule: 0-1-6 months
* Alternate immunization schedule: 0-1-2 months
Appearance & Packaging Unit
Slightly opaque white suspension for injection
10 μg/0.5 mL 1, 10 vials, 20 vials
20 μg/1.0 mL 1, 10 vials, 20 vials
Active Ingredient and Capacity
Each mL of Euvax B™ Inj. contains, 20 μg of Purified HBsAg (rDNA) as active ingredient and
0.5 mg of Aluminum hydroxide gel (as Al) as adjuvant.
Store at 2-8°C. Do not freeze.